OncClubAll Oncology NewsPipeline Report
InsightsMedical World NewsOncChatsOncLive News Network®OncLive TVPeer ExchangePodcastsRapid ReadoutsThe Talk
Conference CoverageConference Listing
Giants of Cancer CarePER EventsScientific InterchangesState of the Science Summit / IPCWebinars
Partners
Oncology Live®Oncology FellowsSupplements And Featured PublicationsAll Publications
CME/CE
Biomarker ConsortiumInteractive ToolsLearning ModulesPresentationsSponsored
Print SubscriptioneNewsletter
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
Business Management
CAR T-cell Therapy
COVID-19
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-OncologyImmuno-OncologyImmuno-OncologyImmuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Nursing News
Pediatric Oncology
Precision Medicine in Oncology®Precision Medicine in Oncology®
Sarcomas/TGCT
Supportive Care
Spotlight -
  • REGISTER TODAY to explore data on a novel second-generation BTK inhibitor for adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).
  • Share your views with OncChats
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
Business Management
CAR T-cell Therapy
COVID-19
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-OncologyImmuno-OncologyImmuno-OncologyImmuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Nursing News
Pediatric Oncology
Precision Medicine in Oncology®Precision Medicine in Oncology®
Sarcomas/TGCT
Supportive Care
    • Partners
    • CME/CE
Advertisement

Management of Neuroendocrine Tumors

home / peer-exchange / nets
Advertisement
Neuroendocrine Tumors: Introduction and Overview

EP. 1: Neuroendocrine Tumors: Introduction and Overview

March 14th 2013
Histological Classification of Neuroendocrine Tumors

EP. 2: Histological Classification of Neuroendocrine Tumors

March 14th 2013
The Role of Biomarkers in Neuroendocrine Tumors

EP. 3: The Role of Biomarkers in Neuroendocrine Tumors

March 14th 2013
Challenges in the Diagnosis of Neuroendocrine Tumors

EP. 4: Challenges in the Diagnosis of Neuroendocrine Tumors

March 14th 2013
Techniques for Diagnosing Neuroendocrine Tumors

EP. 5: Techniques for Diagnosing Neuroendocrine Tumors

March 14th 2013
The Genetics Behind Familial Neuroendocrine Tumors

EP. 6: The Genetics Behind Familial Neuroendocrine Tumors

March 14th 2013
Advertisement
Surgical Treatment of Neuroendocrine Tumors

EP. 7: Surgical Treatment of Neuroendocrine Tumors

March 14th 2013
Role of Somatostatin Analogs in Neuroendocrine Tumors

EP. 8: Role of Somatostatin Analogs in Neuroendocrine Tumors

March 14th 2013
Emerging Treatment Options in Neuroendocrine Tumors

EP. 9: Emerging Treatment Options in Neuroendocrine Tumors

March 14th 2013
Targeted Therapies in Neuroendocrine Tumors

EP. 10: Targeted Therapies in Neuroendocrine Tumors

March 14th 2013
Treating Neuroendocrine Tumors With Chemotherapy

EP. 11: Treating Neuroendocrine Tumors With Chemotherapy

March 14th 2013
Managing NETs in the Community Setting

EP. 12: Managing NETs in the Community Setting

March 14th 2013

Latest Conference Coverage

Lung Responses to Atezolizumab/Bevacizumab Linked With OS in HCC and Pulmonary Metastasis

Second-Line Regorafenib Demonstrates Safety in Advanced HCC, Irrespective of Prior Treatment

First-line Toripalimab Plus Sorafenib Elicits Responses in Unresectable Hepatocellular Carcinoma

Data for Luspatercept Highlight Evolving Treatment Landscape in Lower-Risk MDS

View More Latest Conference Coverage
Advertise
About OncLive
Editorial Board
CancerNetwork.com
CGTlive.com
CureToday.com
OncNursingNews.com
TargetedOnc.com
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777

© 2023 MJH Life Sciences

All rights reserved.
Home
About Us
News
Contact